Liquid Biopsy Detects DNA Markers in Advanced Breast Cancer Within Five Hours

Liquid Biopsy Detects DNA Markers in Advanced Breast Cancer Within Five Hours

A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within five hours. The test, currently a prototype for research use only, potentially could be used to quickly help oncologists determine if cancer treatments are working. Learn more here.

SEE ALL NEWS
Recent Posts
Reduce Your Breast Cancer Risk Novel Blood Test May Detect Cancer Stress Busters: 4 Integrative Treatments Mammogram Age Guidelines: What You Need to Know Transcription Factors Contribute to Subtypes of Colorectal Cancers Johns Hopkins Hepatologists Detect Liver Cancer in Urine Test Johns Hopkins Surgeons Pioneer Combination of Procedures for Patients with Advanced Colorectal Cancer How to Make a Healthy Smoothie Scientists Design a Nanoparticle That May Improve mRNA Cancer Vaccines